McGovern Institute for Brain Research at MIT
The McGovern Institute for Brain Research is an MIT-embedded, nonprofit neuroscience research institute conducting basic and translational brain research, developing enabling technologies such as CRISPR/Fanzor gene editing, optogenetics, and connectomics algorithms, and serving the global academic and biotech research community.
- Company typePrivate
- Founded2000
- HeadquartersCambridge, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What McGovern Institute for Brain Research at MIT does
The McGovern Institute for Brain Research is a nonprofit, multidisciplinary neuroscience research institute within the Massachusetts Institute of Technology, located in Cambridge, Massachusetts. Founded in 2000 through a gift from Patrick J. McGovern and Lore Harp McGovern, it conducts basic and translational research on the brain and nervous system, spanning molecular neuroscience, gene editing, connectomics, cognitive neuroscience, and computational modeling. The institute's core "products" are scientific publications, patented enabling technologies (notably CRISPR-Cas and Fanzor gene-editing systems, optogenetics, expansion microscopy, and the FLSHclust connectomics algorithm), trained scientists, and licensed research reagents and software distributed via repositories such as Addgene. Its approximately 24 principal investigators and two senior research scientists hold joint appointments across MIT's Department of Brain and Cognitive Sciences, the Broad Institute, and the Schwarzman College of Computing.
The institute does not sell products or services commercially. Its revenue mechanics are characteristic of a university-embedded research organization: an endowment from the McGovern family, competitive federal grants (NIH, NSF), philanthropic donations, and technology licensing income generated through patents and reagent/software distribution. Outputs are consumed by academic researchers, biotech and pharma licensees, and increasingly by educational partners such as Learning Ally in randomized controlled trials. Its principal customers — in the sense of downstream users of its tools and findings — are the global academic neuroscience community and commercial entities licensing its IP portfolio for therapeutic and research use. The institute operates as a node within the broader MIT and Cambridge research ecosystem, with formal collaborations spanning the Broad Institute, Max Planck Institute for Multidisciplinary Sciences, York University, and nonprofit partners.
McGovern Institute for Brain Research at MIT firmographics
Firmographics- Name
- McGovern Institute for Brain Research at MIT
- Legal name
- McGovern Institute for Brain Research at MIT
- Website
- https://mcgovern.mit.edu
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- The McGovern Institute for Brain Research is an MIT-embedded, nonprofit neuroscience research institute conducting basic and translational brain research, developing enabling technologies such as CRISPR/Fanzor gene editing, optogenetics, and connectomics algorithms, and serving the global academic and biotech research community.
- Ownership category
- akta.pro rank
McGovern Institute for Brain Research at MIT industry classification
Industry- Product category
- Neuroscience Research
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Neurology/CNS Gene Therapies (HLAAACAH)
- akta.pro secondary industries
- Neurogenetics & Rare Neurologic Diseases (HLAKAIAO), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC), Cognitive & Behavioral Neurology (Dementia/Memory Disorders) (HLAKAIAH)
Keywords
Where McGovern Institute for Brain Research at MIT is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
McGovern Institute for Brain Research at MIT business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- Research Funding and Grants: Primary revenue from competitive research grants including NIH, NSF, and other federal agencies. Also includes funding from private foundations such as Howard Hughes Medical Institute and Simons Foundation.
- Technology Licensing and Commercialization: Revenue from licensing breakthrough technologies (CRISPR, gene editing tools) to biotechnology and pharmaceutical companies. Researchers share reagents via Addgene nonprofit repository.
- Endowed Professorships and Donations: Financial support from endowed chairs (James and Patricia Poitras Professor, Silverman Family Career Development Professorship) and private donors including Patrick J. McGovern Foundation.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
McGovern Institute for Brain Research at MIT product offering
Product offeringCore offering
The McGovern Institute for Brain Research at MIT is a nonprofit academic research institute that conducts fundamental neuroscience research across brain imaging, cellular and molecular neuroscience, cognitive neuroscience, computational neuroscience, genome engineering, neurotechnology, and systems neuroscience. It investigates brain disorders (Alzheimer's, Parkinson's, autism, schizophrenia, etc.) and develops novel therapeutic technologies including gene editing tools, neural interfaces, and brain stimulation methods. The institute also licenses breakthrough technologies (CRISPR, Fanzor) and shares research outputs through open science platforms.
Product overview
McGovern Institute for Brain Research at MIT is a research institute focused on understanding the brain and applying that knowledge to improve human health and well-being. The institute conducts fundamental neuroscience research across multiple focus areas including brain imaging, cellular and molecular neuroscience, cognitive neuroscience, computational neuroscience, genome engineering, neurotechnology, and systems neuroscience. The institute does not offer commercial products or services but conducts research addressing brain disorders such as addiction, ADHD, ALS, Alzheimer's disease, anxiety, autism, bipolar disorder, depression, dyslexia, Huntington's disease, OCD, Parkinson's disease, and schizophrenia.
Differentiator
Problem solved
Functional benefit
Brands
- Edward M. Scolnick Prize in Neuroscience: Annual prize awarded by the institute to recognize outstanding achievements in neuroscience
- Phillip A. Sharp Lecture in Neural Circuits
- McGovern Institute Annual Symposium
Products and services
- McGovern Institute Brain Research Program Comprehensive neuroscience research program spanning brain imaging, cellular and molecular neuroscience, cognitive neuroscience, computational neuroscience, genome engineering, neurotechnology, and systems neuroscience, investigating brain disorders such as Alzheimer's, Parkinson's, autism, schizophrenia, and other conditions.
- CRISPR-Cas9 Gene Editing Technology CRISPR-Cas9 gene editing technology licensed to biotechnology and pharmaceutical companies for therapeutic development, with reagents shared globally through the Addgene nonprofit repository.
- Fanzor Gene Editing System The first programmable RNA-guided DNA-cutting enzyme found in eukaryotes, derived from fungi, algae, amoeba, and clams; can be engineered to edit human cell genomes with improved efficiency and precision compared to CRISPR systems.
- OMEGA Gene Editing Systems OMEGA (Obligate Mobile Element Guided Activity) Systems, a novel gene editing platform developed by the institute's researchers.
- Athinoula A. Martinos Imaging Center Brain imaging research and development center operating as a core subsidiary of the McGovern Institute, providing advanced imaging capabilities for neuroscience research.
- Poitras Center for Psychiatric Disorders Research Research center focused on psychiatric disorders research, operating as a core subsidiary of the McGovern Institute.
- Rare Brain Disorders Nexus (RareNet) Research center focused on rare brain disorders research, operating as a core subsidiary of the McGovern Institute.
- Yang Tan Collective Research center focused on bioengineering and bionics research, operating as a core subsidiary of the McGovern Institute.
Quantifiable outcome
- Discovery of 188 new rare CRISPR systems through algorithmic mining of genomic databases
- +3 more outcomes
Companies that use McGovern Institute for Brain Research at MIT
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
McGovern Institute for Brain Research at MIT technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature6 records
McGovern Institute for Brain Research at MIT partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, significant and minor.
- York UniversitycoreResearch collaboration on visual learning and neural pathway reorganization during object recognition tasks. Published findings in Nature Communications showing how visual learning reshapes neural pathways in the brain's inferior temporal cortex.
- Learning AllysignificantPartnership with Learning Ally to conduct randomized controlled trials validating the Audiobook Solution for K-12 vocabulary improvements. McGovern Institute researchers conducted the study in collaboration with Boston University's Wheelock College of Education, finding significant vocabulary gains when audiobooks were paired with scaffolded instructional supports.
- Boston University's Wheelock College of EducationsignificantCollaborative partner in the randomized controlled trial of Learning Ally's Audiobook Solution, combining McGovern Institute's research expertise with Wheelock's education research focus.
- Max Planck Institute of Biochemistry (Germany)significantCollaborative research partnership on microRNA destruction mechanism. Published study in Nature revealing the 'two-factor authentication' molecular system controlling microRNA degradation through ZSWIM8 E3 ubiquitin ligase.
- Picower Institute for Learning and Memory at MITcoreCollaboration between Earl Miller's lab and Ila Fiete's lab on anesthesia research, discovering common mechanism of brain destabilization across three different anesthesia drugs.
- Brown UniversityminorPlanning clinical trial of anesthesia monitoring device that measures brain stability using EEG and automatically adjusts drug dose during surgery.
- Broad Institute of MIT and HarvardcoreOngoing collaborative partnership on CRISPR systems research, including discovery of 188 new CRISPR systems using the FLSHclust algorithm. Zhang lab is based at both McGovern Institute and Broad Institute.
- National Center for Biotechnology Information (NCBI/NIH)coreCollaboration on mining genomic databases for novel CRISPR systems. Used NCBI Whole Genome Shotgun database and Joint Genome Institute databases to discover 188 new rare CRISPR systems.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
McGovern Institute for Brain Research at MIT competitors and assessment
Company assessmentDirect peers
- Salk Institute for Biological Studies: La Jolla-based nonprofit research institute with strong programs in neuroscience, genetics, and systems biology. Comparable in scale, nonprofit model, and emphasis on basic research with translational potential.
- Max Planck Institute for Brain Research: Frankfurt-based Max Planck Institute with parallel mission in fundamental neuroscience, including gene editing and computational neuroscience. Listed as McGovern collaborator on the microRNA/ZSWIM8 study, underscoring direct research overlap.
- Janelia Research Campus (HHMI): HHMI's research campus focused on neuroscience and imaging; operates a similar model of small-group, high-risk basic research with shared infrastructure. McGovern's Sven Dorkenwald trained there, indicating direct research overlap.
- Allen Institute for Brain Science: Seattle-based nonprofit research institute focused on brain science, with major programs in cell types, connectivity, and neural dynamics. Highly comparable to McGovern as a nonprofit, large-scale, multi-PI neuroscience research center.
- The Picower Institute for Learning and Memory at MIT: Sister MIT neuroscience institute focused on learning, memory, and cognitive function. Shares campus, faculty (e.g., Earl Miller), and grants a closely aligned mission with McGovern.
- Stanford Wu Tsai Neurosciences Institute: Stanford's interdisciplinary neuroscience institute combining brain research, neurotechnology, and data science. Comparable as a university-affiliated, multi-disciplinary neuroscience research hub with translational ambitions.
- Kavli Institute for Neuroscience at Yale: Yale's university-affiliated neuroscience institute pursuing fundamental brain research and new technologies. Comparable as a multi-PI basic neuroscience research hub with shared focus on neural circuits and imaging.
Broad incumbents
- Broad Institute of MIT and Harvard: Larger, established biomedical research institute affiliated with MIT and Harvard with overlapping PIs (Feng Zhang holds joint appointment). Comparable in genome engineering and large-scale neuroscience programs, but operates across many disease areas beyond the brain.
- Howard Hughes Medical Institute (HHMI): Large biomedical research organization that funds investigators (including Feng Zhang at McGovern) and operates Janelia. Comparable as a research-funding and research-performing entity focused on biomedical discovery.
Regional players
- RIKEN Center for Brain Science: Japan's leading national neuroscience research center with programs spanning cognitive neuroscience, computational neuroscience, and brain disorders. Comparable in mission but primarily serves Japan/Asia rather than the US.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
McGovern Institute for Brain Research at MIT social profiles
Digital presenceMcGovern Institute for Brain Research at MIT financial estimates
Financial estimateRevenue estimate
Valuation estimate
McGovern Institute for Brain Research at MIT leadership team
Management profileNumber of profiles
Profiles21 records
McGovern Institute for Brain Research at MIT subsidiaries and ownership
Company hierarchySubsidiaries4 records
McGovern Institute for Brain Research at MIT funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
McGovern Institute for Brain Research at MIT M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about McGovern Institute for Brain Research at MIT
What does McGovern Institute for Brain Research at MIT do?
The McGovern Institute for Brain Research at MIT is a nonprofit academic research institute that conducts fundamental neuroscience research across brain imaging, cellular and molecular neuroscience, cognitive neuroscience, computational neuroscience, genome engineering, neurotechnology, and systems neuroscience. It investigates brain disorders (Alzheimer's, Parkinson's, autism, schizophrenia, etc.) and develops novel therapeutic technologies including gene editing tools, neural interfaces, and brain stimulation methods. The institute also licenses breakthrough technologies (CRISPR, Fanzor) and shares research outputs through open science platforms.
Is McGovern Institute for Brain Research at MIT a public or private company?
McGovern Institute for Brain Research at MIT is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was McGovern Institute for Brain Research at MIT founded?
McGovern Institute for Brain Research at MIT was founded in 2000. It employs 5,001 to 10,000 people.
Where is McGovern Institute for Brain Research at MIT based?
McGovern Institute for Brain Research at MIT is headquartered in Cambridge, United States, in the North America region.
How does McGovern Institute for Brain Research at MIT make money?
Three revenue lines are on record. Research Funding and Grants are the primary driver. The others are technology Licensing and Commercialization and endowed Professorships and Donations.
Who are McGovern Institute for Brain Research at MIT's main competitors?
Direct peers on record are Salk Institute for Biological Studies, Max Planck Institute for Brain Research, Janelia Research Campus (HHMI), Allen Institute for Brain Science, The Picower Institute for Learning and Memory at MIT, Stanford Wu Tsai Neurosciences Institute and Kavli Institute for Neuroscience at Yale. Broad incumbents are Broad Institute of MIT and Harvard and Howard Hughes Medical Institute (HHMI). RIKEN Center for Brain Science is listed as a regional player.
Does McGovern Institute for Brain Research at MIT have an API?
No public API is recorded for McGovern Institute for Brain Research at MIT.
What industry is McGovern Institute for Brain Research at MIT in?
McGovern Institute for Brain Research at MIT's product category is Neuroscience Research. Its primary akta.pro industry code is HLAAACAH, Neurology/CNS Gene Therapies, with a secondary code of HLAKAIAO, Neurogenetics & Rare Neurologic Diseases. Its NAICS code is 541714 and its SIC code is 8731.